Study of two strategies to induce follicular wave emergence for assisted reproductive treatments (ART)-a preliminary trial
- PMID: 25701140
- PMCID: PMC4380890
- DOI: 10.1007/s10815-015-0432-3
Study of two strategies to induce follicular wave emergence for assisted reproductive treatments (ART)-a preliminary trial
Abstract
Purpose: This study aimed to induce follicular wave emergence (FWE) using pharmacological (recombinant hCG administration) or mechanical (aspiration of dominant follicle) interventions in infertile women.
Methods: Sixteen infertile women (≤35 years) with indications for in vitro fertilization due to tubal and/or male factor infertility were randomized into three groups: control (n = 6), pharmacological (n = 5) and mechanical (n = 5) groups. Women in both experimental groups underwent serial transvaginal sonograms (TVS) from menstrual cycle day 10 until identification of a dominant follicle ≥15 mm. Women in the pharmacological group received 250 μg of recombinant-hCG to induce ovulation, and resumed serial TVS 2 days later. In the mechanical group, dominant and subordinate follicles ≥10 mm were aspirated, and daily TVS was resumed on the following day. An increased pool of follicles ≥5 and ≤9 mm after interventions characterized FWE. Women in the control group underwent ovulation induction (OI) with 150 IU/day of recombinant follicle-stimulating hormone started on menstrual cycle day 3 (D3). OI was started on the day of FWE in the experimental groups. Endometrial asynchrony with development of the embryo was expected in the experimental groups. Therefore, all viable embryos were cryopreserved and transferred in an endometrial-stimulated cycle.
Results: The number of follicles ≥5 and ≤9 mm increased after the interventions in both experimental groups (p < .001), indicating induction of FWE. OI outcomes were similar among the groups.
Conclusions: The pharmacological and mechanical interventions are efficient in inducing FWE; outcomes of OI synchronized with FWE should be further investigated.
Trial registration: ClinicalTrials.gov NCT01668056.
Figures


Similar articles
-
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953. J Clin Endocrinol Metab. 2003. PMID: 12970285 Clinical Trial.
-
Comparison between transabdominal and transvaginal ultrasound in the evaluation of a multiple follicular growth.Acta Eur Fertil. 1992 Jul-Aug;23(4):167-70. Acta Eur Fertil. 1992. PMID: 1343471
-
Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.J Reprod Med. 2014 Jul-Aug;59(7-8):355-66. J Reprod Med. 2014. PMID: 25098025 Clinical Trial.
-
Review: follicular waves in the human ovary: a new physiological paradigm for novel ovarian stimulation protocols.Reprod Sci. 2010 Dec;17(12):1067-76. doi: 10.1177/1933719110366483. Epub 2010 May 3. Reprod Sci. 2010. PMID: 20439948 Review.
-
Flexible ovarian stimulation in a poor responder: a case report and literature review.Reprod Biomed Online. 2013 Apr;26(4):378-83. doi: 10.1016/j.rbmo.2012.11.020. Epub 2012 Dec 8. Reprod Biomed Online. 2013. PMID: 23497915 Review.
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical